专利号:US-10457640-B2 优先权日:2016-10-19 标 题:Synthesis of inhibitors of EZH2 发明人:VASWANI RISHI G; HEWITT MICHAEL CHARLES 权利人:CONSTELLATION PHARMACEUTICALS INC 摘要:Provided herein are synthetic methods for the preparation of EZH2 inhibitors.
专利号:US-2019233375-A1 优先权日:2016-10-19 标题:Synthesis of inhibitors of ezh2
专利号:US-2025236590-A1 优先权日:2021-10-20 标题 :A method for the preparation of indole-3-carboxylic acid derivatives 发明人:DEB INDUBHUSAN 权利人:DEB INDUBHUSAN 摘要:The present invention provides a new synthetic method for the preparation of building block indole-3-carboxylic acid (ICA) derivatives used as a key starting material to produce several artificial drugs. An efficient, safe, operationally simple, cost-effective method for the preparation of several ICA derivatives has been introduced in a very simple way. Utilizing easily available starting material, reagent, and solvent several key starting materials of ICA derivatives have been synthesized rapidly indicates the novel method is functional group tolerable. The preparation process does not involve use of any reducing agents or transition metals in the economically viable and operationally simple condition in one pot. ICA derivatives have been generated from isatin derivative in one step and this methodology is important with a wide range of applications from the drug development and material synthesis CN point of view.
专利号:EP-3529242-A1 优先权日:2016-10-19 标 题 :Synthesis of inhibitors of ezh2
专利号:WO-2018075598-A1 优先权日:2016-10-19 标题 :Synthesis of inhibitors of ezh2
1: Vaswani RG, Gehling VS, Dakin LA, Cook A, Nasveschuk CG, Duplessis M, Iyer P, Balasubramanian S, Zhao F, Good AC, Campbell R, Lee C, Cantone N, Cummings RT, Normant E, Bellon SF, Albrecht BK, Harmange JP, Trojer P, Audia JE, Zhang Y, Justin N, Chen S, Wilson J, Gamblin S. Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1 -(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas. J Med Chem. 2016 Oct 14.
合成参考文献
参考文献:10.1016/j.ejmech.2024.116470 摘要:Long L, Zhang H, Zhou Z, Duan L, Fan D, Wang R, Xu S, Qiao D, Zhu W. Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and structure-activity relationships. European Journal of Medicinal Chemistry. 2024 Jul;273():116470. doi: 10.1016/j.ejmech.2024.116470.